Riskpilot← Back to searchSign inGet full accessHälsooffensiven i Göteborg AB
ABActiveOrg 5563262780Kristinelundsgatan 16Other education n.e.c. · NACE 8559Est. 19880 employees
Revenue 2024
SEK 944K
-12% vs 2023
EBITDA margin
-2.0%
-110% vs 2023
Equity ratio
67.6%
Financial strength
Net profit 2024
SEK 377K
+20% vs 2023
| Revenue | SEK 944K | -12% |
| EBITDA | SEK -19K | -110% |
| Net profit | SEK 377K | +20% |
| Total assets | SEK 2,5M | +28% |
| Equity | SEK 1,7M | +12% |
| Employees | 0 | — |
Legal name
Hälsooffensiven i Göteborg AB
Org number
5563262780
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
26 maj 1988
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva legitimerad naprapatverksamhet, legitimerad psykoterapeuverksamhet med KBT-inriktning, att äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Kristinelundsgatan 16
Phone
+4630359140
Email
annett@halsooffensiven.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 383 | 1 153 | 986 | 1 072 | 944 |
| Staff expenses | — | — | −1 359 | −707 | −784 |
| EBITDA | 625 | −427 | −592 | 179 | −19 |
| Depreciation & amort. | −8 | −8 | −8 | −6 | — |
| EBIT | 617 | −435 | −600 | 172 | −19 |
| Net financials | 35 | 35 | 38 | 56 | 32 |
| Profit before tax | 653 | −392 | −407 | 314 | 377 |
| Tax | −140 | −0 | — | — | — |
| Net profit | 513 | −392 | −407 | 314 | 377 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 637 | 2 399 | 2 238 | 1 968 | 2 523 |
| Equity | 2 413 | 2 021 | 1 614 | 1 528 | 1 705 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 216 | 378 | 623 | 440 | 819 |
| Total debt | 216 | 378 | 623 | 440 | 819 |
EBITDA margin
-2.0%
This company
15.8%
Market median
-113% vs market
20202024
Equity ratio
67.6%
This company
38.2%
Market median
+77% vs market
20202024
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
20202024
Net profit margin
39.9%
This company
8.1%
Market median
+393% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsooffensiven i Göteborg AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Gunnar Selheden | Deputy Board Member | 0 companies |
| Annett Glasin Selheden | Board of Directors | 0 companies |